[Endothelial dysfunction in patients with diabetes: identification, pathogenesis and treatment]

Area of Science:

• Cardiovascular Medicine
• Endocrinology
• Vascular Biology

Context:

• Cardiovascular diseases are the primary cause of death in diabetic patients.
• Vascular abnormalities and endothelial dysfunction, including impaired nitric oxide bioavailability, precede atherosclerosis development in diabetes.
• Hyperglycemia directly exacerbates oxidative stress, worsening endothelial function.

Purpose:

• To elucidate the mechanisms linking diabetes, endothelial dysfunction, and cardiovascular complications.
• To investigate the role of oxidative stress and nitric oxide in diabetes-related vascular abnormalities.
• To evaluate the efficacy of antioxidant therapy versus glycemic control for cardiovascular prevention in diabetes.

Summary:

• Endothelial dysfunction in diabetes, characterized by reduced nitric oxide bioavailability and impaired vasodilation, is driven by oxidative stress.
• Hyperglycemia amplifies oxidative stress, leading to endothelial activation of NF-kappaB and LDL oxidation, key events in atherosclerosis.
• While antioxidants offer transient benefits, controlling hyperglycemia is the most effective strategy for improving endothelial function and preventing cardiovascular disease in diabetes.

Impact:

• Highlights oxidative stress as a central mediator of endothelial dysfunction and atherosclerosis in diabetes.
• Underscores the critical importance of glycemic control for cardiovascular risk reduction in diabetic individuals.
• Provides evidence against the preventive efficacy of antioxidant therapy, redirecting focus to metabolic management.